Drug patent regime has led to high prices: Study
28 January 2010
39 views
No Comment
As drug multinationals from the United States demand a stronger intellectual property regime that gives exclusive marketing rights for their patented medicines in India, their own government has said the IP system is partly responsible for the extraordinary increase in prices for some medicines in the US.
Go to Source
(No Ratings Yet)
Loading ...
Leave your response!